154 related articles for article (PubMed ID: 35197448)
21. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.
Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A
Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis reveals NRP1 as a direct HIF1α-E2F7 target in the regulation of motorneuron guidance in vivo.
de Bruin A; A Cornelissen PW; Kirchmaier BC; Mokry M; Iich E; Nirmala E; Liang KH; D Végh AM; Scholman KT; Groot Koerkamp MJ; Holstege FC; Cuppen E; Schulte-Merker S; Bakker WJ
Nucleic Acids Res; 2016 May; 44(8):3549-66. PubMed ID: 26681691
[TBL] [Abstract][Full Text] [Related]
23. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.
Xiang S; Wang Z; Ye Y; Zhang F; Li H; Yang Y; Miao H; Liang H; Zhang Y; Jiang L; Hu Y; Zheng L; Liu X; Liu Y
Oncogene; 2019 Feb; 38(8):1269-1281. PubMed ID: 30254209
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cells.
Luo Y; Wang L; Ran W; Li G; Xiao Y; Wang X; Zhao H; Xing X
Cancer Cell Int; 2020; 20():43. PubMed ID: 32055236
[TBL] [Abstract][Full Text] [Related]
25. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.
Endo-Munoz L; Dahler A; Teakle N; Rickwood D; Hazar-Rethinam M; Abdul-Jabbar I; Sommerville S; Dickinson I; Kaur P; Paquet-Fifield S; Saunders N
Cancer Res; 2009 Mar; 69(5):1800-8. PubMed ID: 19223542
[TBL] [Abstract][Full Text] [Related]
26. E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation.
Mitxelena J; Apraiz A; Vallejo-Rodríguez J; Malumbres M; Zubiaga AM
Nucleic Acids Res; 2016 Jul; 44(12):5557-5570. PubMed ID: 26961310
[TBL] [Abstract][Full Text] [Related]
27. The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes.
Baker AL; Du L
J Cancer; 2022; 13(7):2374-2387. PubMed ID: 35517423
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells.
Islam MS; Tatsumi Y; Takano R; Yokochi T; Akter J; Ozaki T; Nakamura Y; Ohira M; Nakagawara A
Biochem Biophys Res Commun; 2016 Sep; 478(1):81-86. PubMed ID: 27453342
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G
J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818
[TBL] [Abstract][Full Text] [Related]
30. RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
Hazar-Rethinam M; de Long LM; Gannon OM; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Saenz-Ponce N; Dantzic DD; Simpson F; Saunders NA
Mol Cancer Ther; 2015 Aug; 14(8):1939-50. PubMed ID: 26018753
[TBL] [Abstract][Full Text] [Related]
31. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
32. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
[TBL] [Abstract][Full Text] [Related]
33. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma.
Tan F; Wahdan-Alaswad R; Yan S; Thiele CJ; Li Z
Cancer Sci; 2013 Dec; 104(12):1586-92. PubMed ID: 24011394
[TBL] [Abstract][Full Text] [Related]
34. Atypical E2Fs inhibit tumor angiogenesis.
Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
[TBL] [Abstract][Full Text] [Related]
35. Elevated E2F7 expression predicts poor prognosis in human patients with gliomas.
Yin W; Wang B; Ding M; Huo Y; Hu H; Cai R; Zhou T; Gao Z; Wang Z; Chen D
J Clin Neurosci; 2016 Nov; 33():187-193. PubMed ID: 27460513
[TBL] [Abstract][Full Text] [Related]
36. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3786-3794. PubMed ID: 32329855
[TBL] [Abstract][Full Text] [Related]
37. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
38. MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Yin J; Peng B; Zhou B; He X; Liu W
Oncotarget; 2016 Feb; 7(8):9222-35. PubMed ID: 26824182
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
Subhash VV; Yeo MS; Wang L; Tan SH; Wong FY; Thuya WL; Tan WL; Peethala PC; Soe MY; Tan DSP; Padmanabhan N; Baloglu E; Shacham S; Tan P; Koeffler HP; Yong WP
Sci Rep; 2018 Aug; 8(1):12248. PubMed ID: 30115935
[TBL] [Abstract][Full Text] [Related]
40. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.
Salvatori B; Iosue I; Mangiavacchi A; Loddo G; Padula F; Chiaretti S; Peragine N; Bozzoni I; Fazi F; Fatica A
Cell Death Dis; 2012 Oct; 3(10):e413. PubMed ID: 23096114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
